Plerixafor Injection

Plerixafor Injection

Product Details:

  • Origin of Medicine Synthetic
  • Pacakaging (Quantity Per Box) 1 vial per box
  • Salt Composition Plerixafor 20 mg/mL
  • Drug Type Injection
  • Ingredients Plerixafor
  • Physical Form Liquid
  • Function Used in combination with a granulocyte-colony stimulating factor to mobilize hematopoietic stem cells for collection and transplantation in patients with non-Hodgkins lymphoma and multiple myeloma.
  • Click to View more
X

Plerixafor Injection Product Specifications

  • Patients undergoing hematopoietic stem cell mobilization during treatment for non-Hodgkins lymphoma or multiple myeloma.
  • Administered subcutaneously approximately 11 hours before apheresis. The dosage should depend on the patients body weight and under medical supervision.
  • Store at 2°C to 8°C (36°F to 46°F) and protect from light.
  • Available in 1.2 mL and 2 mL vial sizes.
  • Plerixafor
  • Injection
  • Plerixafor 20 mg/mL
  • Used in combination with a granulocyte-colony stimulating factor to mobilize hematopoietic stem cells for collection and transplantation in patients with non-Hodgkins lymphoma and multiple myeloma.
  • Liquid
  • 0.24 mg/kg body weight administered subcutaneously not exceeding 40 mg per dose.
  • 1 vial per box
  • Adults with non-Hodgkins lymphoma or multiple myeloma.
  • Synthetic

Other Products in 'Pharmaceutical Capsules' category



Get in touch with us
RFQ Request For Quotation
Get Quotes For Your Buying Requirement. Tell Suppliers What You Need.
I agree to abide by all the Terms and Conditions of tradeindia.com